Targeted Therapy for Adrenocortical Carcinoma: A Genomic-Based Search for Available and Emerging Options

SIMPLE SUMMARY: Adrenocortical carcinoma is a rare disease for which in silico analysis may help to identify therapy options. Here, we look at the potential of already FDA-approved drugs and therapies in clinical trials based on genes mutated in ACC and genomic alterations known to be targeted by th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hescheler, Daniel Alexander, Hartmann, Milan Janis Michael, Riemann, Burkhard, Michel, Maximilian, Bruns, Christiane Josephine, Alakus, Hakan, Chiapponi, Costanza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179357/
https://www.ncbi.nlm.nih.gov/pubmed/35681700
http://dx.doi.org/10.3390/cancers14112721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179357/
https://www.ncbi.nlm.nih.gov/pubmed/35681700
http://dx.doi.org/10.3390/cancers14112721

Ejemplares similares